We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Metagenomics Analysis Tool Reduces False Discovery Rates

By LabMedica International staff writers
Posted on 30 Mar 2015
Genomic researchers recently described a novel new tool for analyzing the complex data generated during DNA screens of mixed populations of organisms such as the human gut microbiome.

DNA screening of entire communities of organisms has been termed metagenomics. More...
Such screening generates an enormous data set of short sequences, or "reads," which must be evaluated in order to yield meaningful information. While existing microbial community profiling methods have attempted to rapidly classify the millions of reads output from modern DNA sequencing platforms, the combination of incomplete databases, similarity among otherwise divergent genomes, errors and biases in sequencing technologies, and the large volumes of sequencing data required for metagenome sequencing has led to unacceptably high false discovery rates (FDR).

To correct these problems, investigators at the Los Alamos National Laboratory (New Mexico, USA) developed a new method for analysis of DNA sequencing data. The new tool, described in the March 12, 2015, online edition of the journal Nucleic Acids Research, is called Genomic Origins through Taxonomic CHAllenge or GOTTCHA, which makes use of a database of reference genomes that have been preprocessed to retain only unique segments of the genomes at any level of taxonomy.

GOTTCHA analyzes the distribution and depth of coverage of only the unique fraction of each reference genome—the unique genome—to identify the true community composition and accurate relative abundance of members of the community. GOTTCHA uses empirically-derived coverage limits, supported by machine-learning approaches, to set the limits of detection. The result is a scalable, all-purpose, metagenomic community profiler with superior classification and statistical performance over all currently available tools.

"We have developed a new tool in this rapidly expanding and evolving field of what is called metagenomics," said senior author Dr. Patrick Chain, metagenomics team leader at the Los Alamos National Laboratory. "It uses nucleic acid data and looks for sections that map uniquely to a preconstructed database."

"Metagenomics is the study of entire microbial communities using genomics, such as when you sequence the DNA of a whole community of organisms at once," said Dr. Chain. "The result is an enormous data set of short sequences, or reads, that you need to sort through to try to understand which organisms are actually present, and what they may be doing. Here at Los Alamos, we specialize in incredibly large data sets; we know how to handle them whether it is for physics, ocean, or climate modeling, or for complex biological insights."

The GOTTCHA software, associated databases, and training datasets are accessible to biotech researchers online (please see Related Links below).

Related Links:
Los Alamos [US] National Laboratory
GOTTCHA



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.